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Methods Two independent, trained investigators searched 
MEDLINE, EMBASE and CENTRAL for eligible studies 
published before 1 January 2015. Also, they hand-searched 
the conference proceedings of the annual scientific ses-
sions of the American College of Cardiology, the American 
Heart Association, European Society of Cardiology, and the 
Trans-catheter Cardiovascular Therapeutics. Inclusion cri-
teria were cohort studies and clinical trials discussing the 
incidence of access-site complications and upper extrem-
ity function after transradial percutaneous coronary inter-
vention (TR-PCI) and/or transradial coronary angiography 
(TR-CAG) as endpoints.
Results 176 articles described access-site complications. 
The incidence is up to 9.6 %. Fourteen articles described up-
per extremity dysfunction, with an incidence of up to 1.7 %. 
Upper extremity dysfunction was rarely investigated, hardly 
ever as primary endpoint, and if investigated not thoroughly 
enough.
Conclusion Upper extremity dysfunction in TR-PCP has 
never been properly investigated and is therefore underesti-
mated. Further studies are needed to investigate the magni-
tude, prevention and best treatment of upper extremity dys-
function. Optimising TR-PCP might be achieved by using 
slender techniques, detection of upper extremity dysfunc-
tion and early referral to a hand rehabilitation centre.
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Introduction
Little is known about the impact of access-site and proce-
dural complications on upper extremity function after tran-
sradial percutaneous coronary interventions (TR-PCI) and 
Abstract
Objectives Little is known about local access-site compli-
cations and upper extremity dysfunction after transradial 
percutaneous coronary procedures (TR-PCP). This system-
atic review study aimed to summarise the current knowl-
edge on the incidences of access-site complications and up-
per extremity dysfunction after TR-PCP.
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transradial coronary angiography (TR-CAG) even though 
the transradial route is quickly becoming the golden stan-
dard for many interventional cardiologists [1]. In 2013, 
over 85 % of all PCIs at our hospital were performed using 
the radial artery. In comparison, in the third quarter of 
2012 only 16.9 % of all PCIs in the USA were performed 
using this approach [2]. This appreciation of TR-PCI and 
TR-CAG, summed up under the heading of the transradial 
percutaneous coronary procedures (TR-PCP), stems from 
innovations in the field of material science. Refinement of 
materials, such as hydrophilic sheaths and miniaturisation 
of equipment, has increased the therapeutic options, thus 
making TR-PCP elegant, safe and feasible [2–4]. This was 
confirmed in a comprehensive meta-analysis of randomised 
clinical trials by Jolly et al. [3]. They compared radial ver-
sus femoral access and showed a 73 % reduction in major 
bleeding and a trend towards reductions of mortality, myo-
cardial infarction and stroke in favour of the radial route 
[3]. Additionally, TR-PCP is associated with lower costs 
and higher patient satisfaction, correlating with a higher 
quality of life [4]. However, TR-PCP is technically more 
challenging with a long learning curve [5–7], partly due to 
the complex anatomical variability of the nerves and blood 
vessels in the upper extremity (Fig. 1; [8–10]) This makes 
TR-PCP more susceptible to functional complications. To 
understand the impact of access-site complications and its 
effect on upper extremity function a clear definition of the 
latter is needed and this has been much debated. Traditional 
clinical assessment has focused on grip or pinch strength 
and range of motion [11, 12]. A much more encompassing 
definition would be ‘the physiological capacity in which a 
patient can use an anatomically unaffected upper limb in 
everyday activities’. To evaluate this, several aspects should 
be considered. It comprises anatomy, including blood and 
lymph circulation, muscle strength, active range of motion, 
coordination and sensory functions. Pain affects all of these 
parameters (Fig. 2). Adequate knowledge of complications 
is necessary to prevent dysfunction. Current reviews have 
not described upper extremity function [13–15]. This study 
aimed to summarise the current knowledge on the inci-
dences of access-site complications and upper extremity 
dysfunction after TR-PCP.
Methods
Two independent, trained investigators searched MEDLINE, 
EMBASE and CENTRAL for eligible studies published 
before 1 January 2015. Search keywords included: “radial 
artery”, “percutaneous coronary intervention”, “coronary 
angiography” and “complications”. Various combinations 
of these terms were used depending on the requirements of 
the database. Language was not restricted. The investigators 
hand-searched the conference proceedings of the annual sci-
entific sessions of the American College of Cardiology, the 
American Heart Association, European Society of Cardiol-
ogy, and the Trans-catheter Cardiovascular Therapeutics. 
Major reviews regarding the radial approach for coronary 
procedures were systematically searched. Cross-references 
and quoted papers were checked, and experts were con-
tacted to identify other relevant trials.
Selection criteria
Inclusion criteria were cohort studies and clinical trials dis-
cussing the incidence of access-site complications and upper 
Fig. 1 The anatomy of the upper extremity (a) and its variations (b). 
a The anatomy of the arteries (red line) and nerves (grey line) of the 
arm leading to the heart. The area where the bifurcation of the radial 
artery might occur is accentuated; this area is prone to perforation 
(inner dashed box). The area where spasm, occlusion or damage to 
vasa nervorum occurs is also highlighted (outer dashed box). Hydro-
philic guiding catheters and special radial access closure devices might 
reduce the incidence of these complications and could diminish the 
impact on upper extremity function. b Frequent variations of the take-
off of the radial artery. The radial artery ® and ulnar artery (U) are illus-
trated. 1. Radial artery arising from the brachial artery. 2. Independent 
radial artery arising from the axillary artery. 3. Radial artery arising 
from the axillary artery with a contribution from the brachial artery. 4. 
Slender artery arising from the axillary artery continuing as the radial 
artery. The major blood supply to the radial artery is supplied by the 
brachial artery. This type is highly susceptible to perforation.
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Endpoint definitions
The primary clinical outcome was upper extremity dysfunc-
tion, defined as loss of strength, sensory loss, coordination 
loss and/or loss of active range of motion, ascertained by 
patient history and/or through physical examination. Upper 
extremity ischaemia was defined as necrosis, symptomatic 
embolisation or thrombosis and claudication. Pain was 
defined as paraesthesia and/or a visual analogue score of ≥ 5 
per procedure, post procedure or at follow-up. Non-severe 
radial artery spasm was defined as operator perceived or 
radiological confirmed spasm, while severe radial artery 
spasm was the inability to advance the guide wire and/or the 
inability to remove the sheath. Furthermore, radial artery 
occlusion was defined as a completely occluded artery con-
firmed by Doppler or angiography during hospital admis-
sion (early) or at follow-up (late). Access-site haematoma 
was defined as minor (< 5 cm) or major (≥ 5 cm); access-
site (prolonged) bleeding as requiring additional compres-
sion (minor) or blood transfusion and/or a haemoglobin 
drop of ≥ 3 mmol/L (major). Perforation was confirmed by 
angiography and dissection by angiography. Swelling and 
oedema were assessed visually and not attributed to bleed-
ing. Compartment syndrome, as diagnosed by the opera-
tor, and requiring treatment; pseudo-aneurysm, requiring 
treatment; arteriovenous fistula, as diagnosed by the opera-
tor; and inflammation was defined as local inflammation, 
abscess and/or mycotic aneurysms.
Data analysis and synthesis
Statistical analysis was performed using the R software pro-
gramming language [16]. Pooled estimates were calculated 
for the incidence of previously mentioned clinical outcomes. 
A summary of pooled-effect estimates and corresponding 95 % 
CIs was derived by using the DerSimonian-Laird random-
effects model [17]. The random-effects method was chosen 
because it incorporates between- and within-study variance. To 
assess heterogeneity a Cochrane Q-statistic test and the I2 statis-
tic were used [18]. Funnel plots were used to assess publication 
bias [19]. If high heterogeneity was observed, meta-regression 
analysis, using the test of moderators, was conducted.
Results
A total of 869 citations were evaluated. After careful selec-
tion 176 papers were eligible (Fig. 3). The pooled incidence 
rates of upper extremity complications after TR-PCP, TR-
PCI and TR-CAG are shown in Table 1. We did produce 
funnel and forest plots, but because of the extent of all the 
results, we do not show these in this article.
extremity function after TR-PCI and TR-CAG as endpoints. 
Due to the limited information available, we used some case 
reports for a subsection regarding upper extremity dysfunc-
tion. Editorials, reviews and letters were excluded, as well 
as articles with incomplete data.
Fig. 2 Complications after transradial percutaneous coronary proce-
dures (TR-PCP) and the impact on upper extremity function. All com-
plications affect upper extremity function after TR-PCP. The mecha-
nism and the magnitude in which they affect function is partly known 
and partly unknown (black box). The circle below represents upper 
extremity function and the negative impact complications might have. 
a Very little is known about complications affecting upper extremity 
function after TR-PCP (red circle without overlap). However, there 
is awareness for the overlap part. Access-site complications (inner 
white circle) are described in the literature (Table 1). Major adverse 
cardiac and cerebral events (MACCE) (outer white circle) might influ-
ence upper extremity function as well, but were not investigated in 
this article. b Upper extremity function consists of several important 
physiological capacities as mentioned in the pie diagram. Pain is not a 
physiological parameter, but negatively affects all parameters of upper 
extremity function
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of motion at 10-day follow-up [22]. Likewise, no functional 
complaints were reported by De Belder et al. They described 
75 patients who underwent TR-PCP with a follow-up at 4–6 
weeks. Nevertheless, they found 1 patient with transient 
paraesthesia [23]. While Kiemeneij et al. described 100 
cases of radial artery occlusion after TR-PCI, no cases of 
upper extremity dysfunction were found at 1–3 months of 
follow-up. Functional disability was defined as the ability 
to repeatedly open and close the catheterised hand 50 times 
[24]. Nerve damage was mentioned as an endpoint in two 
articles. They found no cases of nerve damage [25, 26]. 
Seven articles, where functional outcome was not a soli-
tary endpoint, described cases with nerve damage [27–33]. 
Lotan et al. described a case with sensory loss of the thumb 
and index finger at 1 month [27]. Similarly, Tharmaratnam 
et al. reported 22 patients with either distal (typically thumb) 
pain, or paraesthesia in the hand [28]. Additionally, Chat-
elain et al. described 159 patients who underwent TR-PCP; 
one of these patients with chronic radial occlusion com-
plained of paraesthesia in the right thumb during exercise at 
discharge [29]. Tewari et al. found three patients who devel-
oped transient neurological deficit post procedure, without 
any residual deficit [30]. Median nerve compression due to a 
large haematoma, which resolved within 48 h, was reported 
by Spaulding et al. [31]. In another case described by Tizon-
Marcos et al. a pseudo-aneurysm resulted in compartment 
syndrome causing a Volkmann’s contracture, a debilitating 
permanent claw-like deformity [32]. Zankl et al. reported a 
case of persistent radial thrombosis, with unknown casualty, 
leading to radial nerve paresis [33].
Upper extremity ischaemia
A total of 45 articles described upper extremity dysfunc-
tion after TR-PCP, with a pooled incidence of up to 0.3 % 
(Table 1; [8, 21, 22, 24, 29–31, 33–66]) The majority of 
articles described no ischaemia or claudication. However, 
necrosis leading to amputation of the index finger was 
described in 1 article [34]. Timely intervention with appro-
priate methods may reduce the need for amputations.
Pain
Severe pain (VAS ≥ 5) was reported in 16 articles and had 
a pooled incidence of up to 9.6 % (Table 1; [25, 28, 34, 35, 
49, 67–75]) The majority of the articles described peri-pro-
cedural pain. Studies used a wide variety of scoring meth-
ods, whereupon we excluded many studies. Since there was 
no unequivocal classification, findings must be interpreted 
carefully. Pain, especially when chronic, affects all func-
tional parameters and can be very debilitating. Knowledge 
of causality and location is essential for treatment and pre-
Upper extremity dysfunction
Fourteen articles described upper extremity dysfunc-
tion after TR-PCP, with a pooled incidence of up to 1.7 % 
(Table 1). Two articles objectively measured upper extrem-
ity dysfunction after TR-PCP. Wu et al. described hand-
strength of both arms retrospectively 1 year after TR-PCI. 
Twenty-four patients underwent 8Fr coronary procedures 
and 16 patients 6Fr procedures. There was no significant 
difference between groups, nor when comparing opposite 
arms [20]. Valgimigli et al. showed that Allen’s test did not 
influence handgrip strength, as was measured before, at 1 
day, 1 month and 1 year after the procedure [21]. Evalua-
tion of functional loss by history of follow-up was reported 
in three articles [22–24]. Prull et al. described 93 patients 
who underwent TR-PCP. None of them reported sensory 
loss, diminished strength, coordination and/or active range 
Fig. 3 Inclusion flow diagram. Using MEDLINE, EMBASE and 
CENTRAL 869 articles were obtained concerning access-site compli-
cations after trans radial percutaneous coronary procedures (TR-PCP). 
There were 376 cohort studies and clinical trials. After careful selec-
tion 176 articles were included based on the inclusion criteria as de-
scribed in the methods
 
518 Neth Heart J (2015) 23:514–524
Complication Mean incidence 
after TR-PCP (%)









0.32 % (0.07–1.51) 0.81 % (0.16–3.91) 0.12 % (0.02–0.72) 0.32 % (0.10–1.01) [20–33]
Upper extremity 
ischaemia
0.14 % (0.04–0.57) 0.29 % (0.16–0.53) 0.19 % (0.04–0.99) 0.21 % (0.10–0.43) [8, 21, 22, 24, 29–31, 33–66]
Pain 8.03 % (3.97–15.55) 4.49 % (0.64–25.43) 9.57 % (7.52–12.11) 7.65 % (4.51–12.67) [25, 28, 34, 35, 49, 67–75]
Radial artery 
spasm
8.7 % (5.8–12.7) 4.24 % (2.47–7.17) 7.25 % (4.01–12.77) 0.5 % (0.01–2.75) [26, 30, 31, 34, 35, 55, 56, 
67, 71, 73, 76–98]
Severe radial 
artery spasm
1.82 % (1.07–3.06) 1.13 % (0.68–1.87) 1.58 % (0.85–2.93) 1.45 % (1.07–1.96) [3, 8, 22, 24, 34, 35, 37, 44, 
46, 53, 55, 65, 66, 71, 72, 76, 




4.0 % (2.67–5.94) 2.59 % (1.81–3.69) 4.98 % (2.34–10.31) 3.45 % (2.59–4.58) [8, 21, 22, 24, 26, 27, 29–31, 
33, 35, 38, 43–47, 49, 50, 52, 
54, 55, 57, 59, 61, 62, 69, 70, 
72, 74, 79, 96, 97, 100, 101, 
104, 115–140]
Late radial artery 
occlusion
3.23 % (2.01–5.15) 3.21 % (2.10–4.87) 3.30 % (1.98–5.46) 3.34 % (2.57–4.32) [20, 21, 23–27, 31, 36, 44, 
46, 48, 53, 55–57, 61, 65, 
67, 71, 72, 76, 86, 89, 93, 




4.30 % (2.35–7.75) 1.93 % (0.61–5.96) 1.56 % (0.93–2.61) 2.49 % (1.29–4.75) [6, 24, 26, 29, 34, 36, 47–49, 
55, 59, 64, 76, 78, 80, 107, 




0.34 % (0.12–0.97) 0.79 % (0.50–1.23) 0.22 % (0.03–1.57) 0.66 % (0.44–0.99) [25, 36, 40, 43, 45, 46, 
56, 60–62, 64, 65, 74, 79, 
101–103, 106, 112, 118, 123, 




3.89 % (2.40–6.25) 3.34 % (2.49–4.47) 1.54 % (0.54–4.32) 3.22 (2.42–4.28) [8, 23, 26, 27, 29–31, 33, 36, 
37, 39, 44, 45, 47, 57, 58, 68, 
71, 72, 76, 80, 86, 89, 92, 
95–97, 100, 103, 107, 108, 
115, 116, 118, 119, 122, 124, 




0.87 % (0.56–1.36) 1.07 % (0.67–1.71) 0.45 % (0.24–0.82) 0.89 % (0.65–1.21) [6, 8, 23, 25, 27, 30, 33, 34, 
37, 39–41, 43, 45, 49–55, 
68–70, 72–74, 76, 80, 86, 9 
0, 100, 101, 105, 107, 108, 
110–113, 116–119, 123–125, 
127, 129, 130, 132, 134, 136, 
139, 142, 145, 146, 150, 152, 
153, 155–159, 162, 163, 165, 
168, 169, 172, 174–189]
Perforation 0.28 % (0.08–0.90) 0.64 % (0.12–3.22) 0.48 (0.16–1.49) 0.40 % (0.20–0.80) [37, 47, 65, 66, 67, 90, 93, 
95, 113, 136, 150, 177, 184, 
190, 191]
Dissection 0.40 % (0.10–1.59) 0.48 % (0.09–2.39) 0.72 % (0.15–3.43) 0.49 % (0.19–1.27) [8, 20, 22, 24, 26, 27, 37, 41, 
50, 51, 73, 90, 101, 102, 186, 
190, 192]
Swelling 2.4 % (1.1–5.3) 3.5 % (0.5–20.6) 1.0 (0.1–6.6) 2.76 % (1.36–5.5) [28, 34, 35, 80, 154]
Compartment 
syndrome
0.01 % (0.0–0.02) 0.14 % (0.03–0.71) 0.0 % (0.0–0.11) 0.0 % (0.01–0.07) [8, 32, 37, 45, 51, 56, 173, 
184]
Table 1  Pooled incidence of complications. Pooled incidence in percentages and range in brackets of reported access-site complications after 
TR-PCP, TR-PCI and TR-CAG
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43 articles and had an incidence of up to 3.3 % (Table 1; 
[20, 21, 23–27, 31, 36, 44, 46, 48, 53, 55–57, 61, 65, 67, 
71, 72, 76, 86, 89, 93, 103–105, 115, 125, 130, 133, 136, 
140–143]). Radial artery occlusion is often asymptomatic 
or subclinical (e.g. only complaints during cold weather or 
heavy exertion). This lack of clinical consequences is attrib-
uted to the dual blood supply of the hand and the forma-
tion of collateral blood vessels. Ischaemia and subsequent 
necrosis due to radial artery occlusion have been reported 
[34, 37, 50]. In the current reviewed studies, a broad variety 
of diagnostic methods was used. The majority of the stud-
ies diagnosed occlusion with Doppler echography, and only 
these protocols were included. Spontaneous recanalisation, 
without prolonged treatment, took place in the majority at 
30 days to 3 months post-procedure [26, 33, 44, 55, 61, 96, 
126, 127]. Occlusion of arteries of the upper extremity other 
than the radial artery is not reported. However, location of 
the occlusion was often not investigated by angiography or 
echography. The majority of the articles did not investigate 
functional outcome.
Access-site bleeding
Minor access-site bleeding was reported in 34 articles, with 
a pooled incidence of up to 4.3 % (Table 1; [6, 24, 26, 29, 
34, 36, 47–49, 55, 59, 64, 76, 78, 80, 107, 108, 116, 119, 
121, 127, 131, 132, 136–138, 144–150]). Forty-five articles 
reported on major access-site bleeding at a pooled rate up to 
0.8 % (Table 1; [25, 36, 40, 43, 45, 46, 56, 60–62, 64, 65, 74, 
79, 101–103, 106, 112, 118, 123, 130, 136–138, 144, 147, 
148, 151–166]). Both major and minor access-site bleeding 
are often described in the literature. Even though bleeding 
and subsequent swelling might have a debilitating impact 
vention; neither were described. Functional outcome was 
not described either.
Radial artery spasm
Analysis of 36 articles showed a pooled incidence of up to 
8.7 % for non-severe radial artery spasm (Table 1; [26, 30, 
31, 34, 35, 55, 56, 67, 71, 73, 76–98]).
Severe radial artery spasm showed a pooled incidence 
of up to 1.8 % extracted from 46 articles (Table 1; [3, 8, 
22, 24, 34, 35, 37, 44, 46, 53, 55, 65, 66, 71, 72, 76, 78, 
79, 81–85, 89, 93–95, 99–113]) There is a wide variety in 
procedural and evaluation methods, with non-severe radial 
artery spasm reported at an incidence of up to 50 % [75], 
and severe radial artery spasm at up to 15 % [77]. There is a 
significant relationship between radial spasm and the base-
line artery diameter, type of spasmolytic drug, the amount 
of catheter changes and the administered volume of contrast 
medium. Another independent predictor of radial artery 
spasm is female gender [71, 78, 81, 83, 85, 97, 114]. Data 
concerning timing, duration and location of arterial spasm 
were sparse [34, 75, 80, 84, 85]. One article described 
subsequent ischaemia [34]. However, none of the articles 
reported functional outcome.
Radial artery occlusion
Sixty-six articles mentioned early radial artery occlusion, 
with pooled incidence rates of up to 5.0 % (Table 1; [8, 21, 
22, 24, 26, 27, 29–31, 33, 35, 38, 43–47, 49, 50, 52, 54, 55, 
57, 59, 61, 62, 69, 70, 72, 74, 79, 96, 97, 100, 101, 104, 
115–140]). Late radial artery occlusion was described in 
Complication Mean incidence 
after TR-PCP (%)









038 % (0.20–0.73) 0.32 % (0.18–0.58) 0.18 % (0.05–0.73) 0.32 % (0.21–0.49) [20, 22, 24, 25, 27, 30, 31, 
36–38, 40, 41, 43–45, 50, 
51, 55–57, 60–62, 69, 73, 
96, 103, 112, 122, 124, 
137–139, 144–146, 148, 
155, 157, 166, 171–173, 




0.20 % (0.09–0.48) 0.22 % (0.11–0.43) 0.19 % (0.05–0.74) 0.21 % (0.13–0.35) [25–27, 30, 31, 36–38, 40, 
41, 43–45, 50, 51, 56, 57, 
60–62, 95, 112, 113, 117, 
136–138, 142, 144, 155, 
166, 179, 184, 188, 191]
Infection/
Inflammation
0.83 % (0.34–1.99) 1.06 % (0.15–7.17) Not applicable 0.86 % (0.38–1.93) [22, 28, 37, 73, 137, 171, 
193]
TR-CAG transradial catheterisation, TR-PCI transradial percutaneous coronary intervention, TR-PCP transradial percutaneous coronary 
procedures.
Table 1 (continued)
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Perforation
Pooled incidence of perforation was reported as up to 0.5 % 
in 14 articles (Table 1; [37, 47, 65–67, 90, 93, 95, 113, 136, 
150, 177, 184, 190, 191]). Perforation of the radial artery or 
its adjacent vessels by the guide wire can result in several 
complications such as bleeding at a remote site proximal 
from the access site, swelling, fistula, pseudo-aneurysm 
and compartment syndrome. The location of the perfora-
tion might influence the severity of the complication and 
the impact on function. However, location was sparsely 
reported [93, 113, 184]. Again, functional outcome was not 
reported.
Dissection
A dissection incidence of up to 0.7 % was shown by the 
pooled dissection data retrieved from 17 articles (Table 1; 
[8, 20, 22, 24, 26, 27, 37, 41, 50, 51, 73, 90, 101, 102, 186, 
190, 192]). Anatomical variations, such as a higher bifurca-
tion of the radial artery, are more prone to dissection [8]. 
Yet location of the dissection was sparsely reported [8, 
22]. Only 1 article investigated functional outcome, which 
was not affected [22]. However, it is unclear how this was 
ascertained.
Swelling
Five articles reported on swelling, with an incidence of up 
to 3.5 % (Table 1; [28, 34, 35, 80, 154]). It is often a benign 
symptom. Nevertheless, it can lead to permanent tissue 
damage, especially to the hand and arm. None of the articles 
described aetiology nor functional outcome at follow-up.
Compartment syndrome
Compartment syndrome was described in 8 studies, up to 
an incidence of 0.14 % (Table 1; [8, 32, 37, 45, 51, 56, 173, 
184]). Tizon-Marcos et al. retrospectively reviewed data of 
TR-PCP and described 2 cases both requiring fasciotomy 
[32]. One patient developed a pseudo-aneurysm which lead 
to compartment syndrome and retained permanent damage. 
The second patient showed complete neuromuscular recov-
ery within 6 years. Aetiology was not ascertained. Also, 
two cases requiring emergency surgery after TR-PCP were 
described by Burzotta et al. They did not describe causality 
and functional outcome [37].
Pseudo-aneurysm
A pooled incidence of 0.04 % for pseudo-aneurysm was 
reported in 52 articles ranging from requiring surgery to 
conservative treatment (Table 1; [20, 22, 24, 25, 27, 30, 31, 
on functional outcome none described the impact of bleed-
ing on functional outcome.
Access-site haematoma
Fifty-five articles reported on minor access-site haematoma, 
with a pooled incidence of 3.9 % (Table 1; [8, 23, 26, 27, 29–
31, 33, 36, 37, 39, 44, 45, 47, 57, 58, 68, 71, 72, 76, 80, 86, 
89, 92, 95–97, 100, 103, 107, 108, 115, 116, 118, 119, 122, 
124, 130, 132, 138, 146, 152, 157, 167–175]). Major access-
site haematoma was reported with a pooled rate of up to 
1.1 % found in 88 articles (Table 1; [6, 8, 23, 25, 27, 30, 33, 
34, 37, 39–41, 43, 45, 49–55, 68–70, 72–74, 76, 80, 86, 90, 
100, 101, 105, 107, 108, 110–113, 116–119, 123–125, 127, 
129, 130, 132, 134, 136, 139, 142, 145, 146, 150, 152, 153, 
155–159, 162, 163, 165, 168, 169, 172, 174–189]). Haema-
tomas ranged from ecchymosis to haematomas requiring 
surgery. Compression of the median nerve was described as 
a result of a major haematoma [31].Haematoma and subse-
quent compression of nerves, blood vessels and surrounding 
tissue might have a debilitating impact. Yet, the majority of 
the articles did not describe location and functional outcome 
in relationship to haematoma.
Table 2 Meta-regression analysis results for primary outcome with 
procedure as covariance. A test of moderators was run by R software 
programming language to find significant differences between access-
site complications and type of procedure. TR-PCI shows more com-
partment syndrome (p = 0.01) and less early radial occlusion artery 
(p = 0.06) in comparison to TR-CAG
Complication Qm df P-value
Upper extremity dysfunction 1.0262 2 0.5986
Upper extremity ischaemia 0.7596 2 0.6840
Pain 0.4701 2 0.7905
Radial artery spasm 3.2052 2 0.2014
Severe radial artery spasm 1.6600 2 0.4360
Early radial artery occlusion 5.0693 2 0.0605
Late radial artery occlusion 0.9621 3 0.8104
Minor access-site bleeding 1.6248 2 0.4438
Major access-site bleeding 2.9380 2 0.2302
Minor access-site haematoma 3.4631 2 0.1770
Major access-site haematoma 4.1858 2 0.1233
Perforation 0.8900 2 0.6408
Dissection 0.2113 2 0.8997
Swelling 1.7717 2 0.4124
Compartment syndrome 8.4838 2 0.0144a
Pseudo-aneurysm 1.0197 2 0.6006
Arteriovenous fistula 0.0378 2 0.9813
Infection/Inflammation 0.0380 1 0.8454
TR-CAG transradial catheterisation, TR-PCI transradial percutaneous 
coronary intervention, Qm Q-model, a measure of model fit.
aSignificant effect of type of procedures on access site complication.
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Discussion
The transradial route is gaining popularity among interven-
tion cardiologists mainly due to lower access-site bleeding 
and lower mortality than with the femoral approach [1–3]. 
With increased use of TR-PCP, upper extremity dysfunction 
may occur more frequently, stressing the need to optimise 
this technique.
The current review reports a mean incidence of known 
access-site complications of up to 9.6 %, which consist 
mainly of radial occlusion, radial spasm, swelling and hae-
matoma (Table 1). Only 14 articles specifically mention 
upper extremity function after TR-PCP with a very low-
pooled incidence of up to 0.8 %. Only 5 of these articles 
measured upper extremity dysfunction as an endpoint [20–
24]. Two articles measured grip-strength [20, 21], yet only 
one as a primary endpoint [20]. This article described a small 
population, was retrospective in nature and used outdated 
equipment. In the other article it was used as a means to 
evaluate the Allen’s test and not for establishing functional 
loss [21]. Three articles evaluated functional loss at follow-
up, but the evaluation strategy to determine upper extremity 
dysfunction was not or insufficiently described. The other 
9 articles mentioned cases in which severe upper extremity 
dysfunction occurred. However, they did not measure it as 
a primary endpoint.
The current reported low incidence of access-site com-
plications post TR-PCP is possibly an underestimation of 
the actual incidence of complications. Many of the articles 
were not primarily focused on access-site complications 
and there is a wide range of reported incidences. Addition-
ally, there is structural underreporting of complications in 
the literature due to negative publication bias and inad-
equate follow-up [194]. Moreover, those centres that pub-
lish their data are often experienced in using the transradial 
approach. However, the complication rate is much higher 
among less experienced cardiologists, due to the learning 
curve [6]. This may lead to a discrepancy between the lit-
erature and day-to-day practice. Our relatively high pooled 
incidences for complications post TR-CAG supposedly also 
reflect an overestimation, while often less experienced car-
diologists perform TR-CAG. In addition, these high inci-
dences (namely in radial artery occlusion; 4.98 %), might 
be an effect of multiple catheter switches. Moreover, in the 
majority of the studies the definitions of the endpoints were 
not specified or unclear, which might give an ambiguous 
rendition of the complication rate. Our hypothesis for the 
significant positive correlation between compartment syn-
drome and TR-PCI is that it is caused by the higher dos-
age of anticoagulants used in TR-PCI, which causes major 
bleeding that can lead to compartment syndrome when not 
treated properly.
36–38, 40, 41, 43–45, 50, 51, 155–57, 60–62 ,69, 73, 96, 103, 
112, 122, 124, 137–139, 144–146, 148, 155, 157, 166, 171–
173, 180, 181, 183, 184, 188, 192]). Only 2 articles reported 
functional outcome in relationship to pseudo-aneurysm [22, 
32]. Just one of them described permanent functional loss 
[22].
Arteriovenous fistula
Arteriovenous fistula had a pooled incidence of up to 0.2 %, 
as was retrieved from 35 studies (Table 1; [25–27, 30, 31, 
36–38, 40, 41, 43–45, 50, 51, 56, 57, 60–62, 95, 112, 113, 
117, 136–138, 142, 144, 155, 166, 179, 184, 188, 191]). 
Fistula might lead to upper extremity dysfunction through 
swelling, which could lead to permanent disability depend-
ing on the severity and location. Nonetheless, neither the 
precise location of the fistula, nor the functional outcome 
were described.
Infection/Inflammation
Seven articles mentioned infection and/or inflammation 
with a pooled incidence of up to 1.1 % (Table 1; [22, 28, 37, 
73, 137, 171, 193]). Only 1 article described the absence 
of upper extremity dysfunction at follow-up [22]. Infection 
and/or inflammation is accompanied by swelling, pain and 
‘functio laesa’. When untreated it can lead to permanent tis-
sue damage in the complex anatomy of the hand and arm.
Meta-regression analysis
The results of the random-effects model also demonstrated 
high statistical heterogeneity and significant high I2 values in 
nearly all outcomes. Therefore, a meta-regression analysis 
was conducted to reduce the heterogeneity associated with 
the incidence of access-site complications. Type of proce-
dure was considered an important covariate in complication 
rate. In order to confirm this with our data a meta-regression 
analysis was conducted with procedure stratifications. Meta-
regression analyses showed a significant positive correlation 
between TR-PCI and compartment syndrome (p = 0.0144) 
(Table 2). Moreover, the results for the correlation between 
early radial artery occlusion and type of procedure suggest a 
trend not beneficial for TR-CAG (p = 0.0605). All the other 
access-site complications showed no significant correlation 
with the type of procedure, which confirms that no differ-
ence should be made regarding the type of procedure, giv-
ing more value to studying all the procedures combined, 
thus TR-PCP. The funnel plot results were not considered 
robust against publication bias.
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taining a small outer lumen, reduces friction and perhaps 
causes less abrasions to the intimae, [195] thus lowering 
the incidence of spasm and occlusion [200]. Furthermore, 
radial access closure devices give adequate pressure with-
out obstructing the radial artery, thus lowering the occlusion 
rate [37]. Patients might benefit from early detection and 
treatment, since cases left untreated might lead to irrevers-
ible injury [32, 201, 202]. This emphasises the need to train 
cardiologists to signal upper extremity dysfunction, which 
could lead to early referral to a hand specialists.
Clearly, there are some limitations to this article. A 
review is dependent upon the information available in the 
literature and there are only 14 articles that mention upper 
extremity dysfunction after TR-PCP [20–33]. Access-site 
complications are frequently mentioned, but those articles 
report little about location, severity, causality, treatment and 
outcome. Therefore, several aspects of this article are based 
on speculation. To gain knowledge about the magnitude and 
impact of upper extremity dysfunction after TR-PCP further 
hypothesising research is needed.
Conclusion
The transradial is favoured above femoral approach in per-
cutaneous coronary procedures (PCP) due to a lower major 
bleeding rate and increased patient comfort. However, 
the pooled incidence of access-site complications is up to 
9.6 %. Furthermore, the rate of upper extremity dysfunction 
is rarely investigated, hardly ever as a primary endpoint, 
and if investigated not thoroughly enough. Therefore, the 
incidence of upper extremity dysfunction is underestimated. 
Nonetheless, it could have significant socioeconomic 
impact. This study may provide a strong basis for a study 
design regarding upper extremity function after TR-PCP. 
Also, TR-PCP can be optimised by additional studies inves-
tigating the magnitude, prevention and best treatment of 
possible upper extremity dysfunction following the use of 
this technique.
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Access-site complications might have a direct relation-
ship with upper extremity dysfunction. The mechanism in 
which previous complications affect upper extremity func-
tion is a complicated cascade of events. It includes, but is 
not limited to, intima damage, hypoxia, soft tissue injury, 
swelling and nerve damage [195, 196]. To illustrate this, it 
should be noted that the main nerves of the upper extremity 
initially are mixed—sensory and motoric [197]—and that 
they have their own blood supply. Damage to this vasa ner-
vorum due to temporary occlusion after spasm can result 
in ischaemia and possibly irreversible nerve damage [34]. 
This affects the motor and sensory functions of the upper 
extremities, thus negatively affecting one or more of the 
physiological parameters of upper extremity function, with 
a potentially debilitating outcome (Fig. 2). The magnitude of 
which depends on anatomical variation and location of the 
complication (Fig. 1). Evaluation of upper extremity com-
prises several factors (Fig. 1). Taking these separate factors 
into account, the incidence of complications is expected to 
be even higher than 9.6 %. When considering the results, 
associations between complications and functional outcome 
are sparsely made in the current literature. However, aeti-
ology and impact are key to understanding and predicting 
complications (Fig. 1).
The perspective and focus of a cardiologist differs from 
that of a hand surgeon for this type of complication. Conse-
quently, a cardiologist could easily overlook upper extrem-
ity dysfunction. This is validated by our finding that only 
one article objectively measured upper extremity dysfunc-
tion as an endpoint after TR-CAG [20].
In addition, patients might be hesitant to complain about 
limb dysfunction after a major cardiac event and cardi-
ologists might be untrained to investigate upper extremity 
function. When unnoticed, complications could be a precip-
itating factor in severe disability, with possibly significant 
socioeconomic consequences on patient and society [198]. 
To understand and prevent the effect of access-site compli-
cations on the function of the upper extremity, knowledge of 
the anatomy of the upper extremity and its numerous ana-
tomical variations is essential (Fig. 1; [195]).
The radial artery is more susceptible to spasm, intimae 
damage and occlusion in some individuals, particularly 
females, the elderly and diabetics whereas the radial artery 
tends to be smaller in calibre [8, 196]. Such patients might 
benefit from prudence, perhaps being treated by expert 
radialists only. Prevention can also be achieved by slender 
percutaneous coronary procedures (PCP) with refinement 
of equipment [199]. Miniaturisation of guiding catheters, 
with diagnostic catheters as small as 3Fr, might be less trau-
matic and reduce the chance of occlusion and perforation 
[199]. The use of hydrophilic or sheathless catheters, with 
excellent torque control and large inner lumen while main-
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